Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

MAb for diagnosis of malignant tumors

Nov. 8, 1996

Eiken contrast agents in development

Nov. 1, 1996

Diatide's P483H Techtide receives patent protection in U.S.

Nov. 1, 1996

Third-generation ultrasound contrast agent from Sonus

Nov. 1, 1996

Schering AG describes radiographic contrast agent

Nov. 1, 1996

MRI contrast agents from Nycomed Salutar

Nov. 1, 1996

Cell motility factor with potential in cancer diagnostics and therapeutics available for licensing

Oct. 25, 1996

Licensees sought for antibodies specific for P31 antigen for use in lung cancer detection

Oct. 25, 1996

IRS-2 polypeptide for diagnosis of insulin- or immune-related disorders available for licensing

Oct. 25, 1996

European approval recommended for LeukoScan

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...